The Commission’s progress report of 26 July 2001 [COM(2001) 444 final.] explained why progress has not been as good as was originally anticipated. The main reasons for the delay were a slow start, due to the identification and priority classification of the substances, the need to bring together the necessary resources and to provide more elaborated procedural schemes for evaluation and decision-making. Based on the conclusions of this report the deadline was extended by Commission Regulation (EC) No 2076/2002 [OJ L 319, 23.11.2002, p. 3. Regulation as last amended by Regulation (EC) No 1765/2004 (OJ L 315, 14.10.2004, p. 26).] for those substances still under review. Meanwhile, the Commission and Member States have worked actively to improve the procedures for assessing active substances, and the considerable increase rate of decisions over the last years show that the learning cycle can be considered closed. EFSA, which bears responsibility in the second stage of the review programme, is also entering an operational phase, and its first opinions have now been delivered. However, some of the reasons identified in the report of 2001 still apply. These include the further need to make the best use of the limited resources by appropriate methods of work-sharing and to ensure that the currently reached number of yearly decisions is maintained. The initial slowness, the technical complexity of certain dossiers, the necessity to obtain the opinion of independent scientific circles and other unforeseen factors, have eroded, in a number of cases, the time necessary for the decision-making and the implementing measures.
Recital 4, Commission Regulation (EC) No 1335/2005 of 12 August 2005 amending Regulation (EC) No 20…
In forcesince 12 Aug 2005